Emergent Biosolutions Inc. Gross Profit

Gross Profit of EBS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Gross Profit growth rates and interactive chart. Gross profit is a company's net sales revenue minus its cost of goods sold (or cost of revenue). In other words, it is the sales revenue a company retains after incurring the direct costs associated with producing the goods it sells, and the services it provides.

Highlights and Quick Summary

  • Gross Profit for the quarter ending June 30, 2023 was $147 Million (a 1373.0% increase compared to previous quarter)
  • Year-over-year quarterly Gross Profit increased by 61.16%
  • Annual Gross Profit for 2022 was $427 Million (a -58.73% decrease from previous year)
  • Annual Gross Profit for 2021 was $1.04 Billion (a 0.37% increase from previous year)
  • Annual Gross Profit for 2020 was $1.03 Billion (a 53.37% increase from previous year)
  • Twelve month Gross Profit ending June 30, 2023 was $360 Million (a 26.05% increase compared to previous quarter)
  • Twelve month trailing Gross Profit decreased by -56.43% year-over-year
Trailing Gross Profit for the last four month:
30 Jun '23 31 Mar '23 31 Dec '22 30 Sep '22
$360 Million $286 Million $427 Million $826 Million
Visit stockrow.com/EBS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Gross Profit of Emergent Biosolutions Inc.

Most recent Gross Profitof EBS including historical data for past 10 years.

Interactive Chart of Gross Profit of Emergent Biosolutions Inc.

Emergent Biosolutions Inc. Gross Profit for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $147.3 $10.0 – – –
2022 $111.3 $91.4 $72.9 $151.6 $427.2
2021 $510.3 $111.5 $169.7 $243.7 $1,035.2
2020 $385.9 $265.0 $264.9 $115.6 $1,031.4
2019 $227.5 $203.8 $142.4 $98.8 $672.5
2018 $157.4 $104.3 $134.9 $63.5 $460.1
2017 $131.59 $104.93 $66.15 $70.54 $373.2
2016 $118.41 $103.35 $61.78 $78.96 $362.5
2015 $114.98 $123.14 $98.85 $44.89 $381.85
2014 $86.27 $105.53 $75.82 $34.89 $302.5
2013 $78.69 $69.04 $65.49 $37.4 $250.62
2012 $79.46 $56.36 – – $235.81

Business Profile of Emergent Biosolutions Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com